Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13.

Tynan JA, Kim SK, Mazloom AR, Zhao C, McLennan G, Tim R, Liu L, Hannum G, Hull A, Bombard AT, Oeth P, Burcham T, van den Boom D, Ehrich M.

Prenat Diagn. 2016 Jan;36(1):56-62. doi: 10.1002/pd.4712. Epub 2015 Dec 23.

PMID:
26505614
2.

Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing.

Kinnings SL, Geis JA, Almasri E, Wang H, Guan X, McCullough RM, Bombard AT, Saldivar JS, Oeth P, Deciu C.

Prenat Diagn. 2015 Aug;35(8):816-22. doi: 10.1002/pd.4625. Epub 2015 Jul 14.

PMID:
26013964
3.

Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts.

Kim SK, Hannum G, Geis J, Tynan J, Hogg G, Zhao C, Jensen TJ, Mazloom AR, Oeth P, Ehrich M, van den Boom D, Deciu C.

Prenat Diagn. 2015 Aug;35(8):810-5. doi: 10.1002/pd.4615. Epub 2015 Jun 3.

PMID:
25967380
4.

Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma.

Zhao C, Tynan J, Ehrich M, Hannum G, McCullough R, Saldivar JS, Oeth P, van den Boom D, Deciu C.

Clin Chem. 2015 Apr;61(4):608-16. doi: 10.1373/clinchem.2014.233312. Epub 2015 Feb 20.

5.

Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples.

McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, Dharajiya N, Saldivar JS.

PLoS One. 2014 Oct 7;9(10):e109173. doi: 10.1371/journal.pone.0109173. eCollection 2014.

6.

Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma.

Mazloom AR, Džakula Ž, Oeth P, Wang H, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, Bombard AT, Maeder M, McLennan G, Meschino W, Palomaki GE, Canick JA, Deciu C.

Prenat Diagn. 2013 Jun;33(6):591-7. doi: 10.1002/pd.4127.

PMID:
23592550
7.

Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.

Perlee LT, Bansal AT, Gehrs K, Heier JS, Csaky K, Allikmets R, Oeth P, Paladino T, Farkas DH, Rawlings PL, Hageman GS.

Ophthalmology. 2013 Sep;120(9):1880-92. doi: 10.1016/j.ophtha.2013.02.007. Epub 2013 Mar 21.

8.

High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma.

Jensen TJ, Zwiefelhofer T, Tim RC, Džakula Ž, Kim SK, Mazloom AR, Zhu Z, Tynan J, Lu T, McLennan G, Palomaki GE, Canick JA, Oeth P, Deciu C, van den Boom D, Ehrich M.

PLoS One. 2013;8(3):e57381. doi: 10.1371/journal.pone.0057381. Epub 2013 Mar 6.

9.

Two algorithms for biospecimen comparison and differentiation using SNP genotypes.

Morris S, Gel ES, Smith JV, Paulauskis JD, Boom Dv, Oeth P, Penny R.

Pharmacogenomics. 2013 Mar;14(4):379-90. doi: 10.2217/pgs.13.21.

PMID:
23438885
10.

Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers.

Moise KJ Jr, Boring NH, O'Shaughnessy R, Simpson LL, Wolfe HM, Baxter JK, Polzin W, Eddleman KA, Hassan SS, Skupski D, McLennan G, Paladino T, Oeth P, Bombard A.

Prenat Diagn. 2013 Jan;33(1):95-101. doi: 10.1002/pd.4018. Epub 2012 Dec 6.

PMID:
23225162
11.

Multiplex protein detection with DNA readout via mass spectrometry.

Flanigon J, Kamali-Moghaddam M, Burbulis I, Annink C, Steffen M, Oeth P, Brent R, van den Boom D, Landegren U, Cantor C.

N Biotechnol. 2013 Jan 25;30(2):153-8. doi: 10.1016/j.nbt.2012.11.003. Epub 2012 Nov 28.

12.

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.

Hageman GS, Gehrs K, Lejnine S, Bansal AT, Deangelis MM, Guymer RH, Baird PN, Allikmets R, Deciu C, Oeth P, Perlee LT.

Hum Genomics. 2011 Jul;5(5):420-40.

13.

Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma.

Tynan JA, Mahboubi P, Cagasan LL, van den Boom D, Ehrich M, Oeth P.

J Mol Diagn. 2011 Jul;13(4):382-9. doi: 10.1016/j.jmoldx.2011.02.001. Epub 2011 May 6.

14.

Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.

Bombard AT, Akolekar R, Farkas DH, VanAgtmael AL, Aquino F, Oeth P, Nicolaides KH.

Prenat Diagn. 2011 Aug;31(8):802-8. doi: 10.1002/pd.2770. Epub 2011 May 31.

PMID:
21626507
15.

Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.

Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, Tang L, Hutchison D, Lu T, Wang H, Angkachatchai V, Oeth P, Cantor CR, Bombard A, van den Boom D.

Am J Obstet Gynecol. 2011 Mar;204(3):205.e1-11. doi: 10.1016/j.ajog.2010.12.060. Epub 2011 Feb 18.

PMID:
21310373
16.

Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing.

Tynan JA, Angkachatchai V, Ehrich M, Paladino T, van den Boom D, Oeth P.

Am J Obstet Gynecol. 2011 Mar;204(3):251.e1-6. doi: 10.1016/j.ajog.2010.09.028. Epub 2010 Nov 18.

PMID:
21092930
17.

Transcript profiling of candidate genes in testis of pigs exhibiting large differences in androstenone levels.

Grindflek E, Berget I, Moe M, Oeth P, Lien S.

BMC Genet. 2010 Jan 25;11:4. doi: 10.1186/1471-2156-11-4.

18.

Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY).

Oeth P, del Mistro G, Marnellos G, Shi T, van den Boom D.

Methods Mol Biol. 2009;578:307-43. doi: 10.1007/978-1-60327-411-1_20.

PMID:
19768603
19.

Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus.

Patel DA, Shih YJ, Newton DW, Michael CW, Oeth PA, Kane MD, Opipari AW, Ruffin MT 4th, Kalikin LM, Kurnit DM.

J Virol Methods. 2009 Sep;160(1-2):78-84. doi: 10.1016/j.jviromet.2009.04.024. Epub 2009 May 3.

20.

Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.

Ehrich M, Field JK, Liloglou T, Xinarianos G, Oeth P, Nelson MR, Cantor CR, van den Boom D.

Cancer Res. 2006 Nov 15;66(22):10911-8.

21.

Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies.

Yang H, Yang K, Khafagi A, Tang Y, Carey TE, Opipari AW, Lieberman R, Oeth PA, Lancaster W, Klinger HP, Kaseb AO, Metwally A, Khaled H, Kurnit DM.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7683-8.

22.

A single nucleotide polymorphism based approach for the identification and characterization of gene expression modulation using MassARRAY.

Jurinke C, Denissenko MF, Oeth P, Ehrich M, van den Boom D, Cantor CR.

Mutat Res. 2005 Jun 3;573(1-2):83-95. Review.

PMID:
15829239
23.

Role of ICAM1 in invasion of human breast cancer cells.

Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, Ekblom J, Denissenko MF.

Carcinogenesis. 2005 May;26(5):943-50. Epub 2005 Mar 17.

PMID:
15774488
24.

Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry.

Tang K, Oeth P, Kammerer S, Denissenko MF, Ekblom J, Jurinke C, van den Boom D, Braun A, Cantor CR.

J Proteome Res. 2004 Mar-Apr;3(2):218-27.

PMID:
15113097
25.

MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis.

Jurinke C, Oeth P, van den Boom D.

Mol Biotechnol. 2004 Feb;26(2):147-64. Review.

PMID:
14764940
26.

Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry.

Amexis G, Oeth P, Abel K, Ivshina A, Pelloquin F, Cantor CR, Braun A, Chumakov K.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12097-102. Epub 2001 Oct 2. Erratum in: Proc Natl Acad Sci U S A 2001 Nov 20;98(24):14186. Brau A [corrected to Braun A].

27.

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J.

Diabetes. 2001 Apr;50(4):886-90.

28.
30.

Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1.

Cui MZ, Parry GC, Oeth P, Larson H, Smith M, Huang RP, Adamson ED, Mackman N.

J Biol Chem. 1996 Feb 2;271(5):2731-9.

32.

Supplemental Content

Support Center